Dyad Oxytocin Study (DOS)
NCT02302209
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
104
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia
Autism Spectrum Disorder
Interventions
DRUG:
Oxytocin
OTHER:
Placebo Comparator
Sponsor
University of California, San Francisco